#MCPro: The business is on the mend for #Lupin in both domestic and US markets. Investors can look forward to a robust product pipeline and an improving margin trajectory.
https://www.moneycontrol.com/news/business/moneycontrol-research/lupin-new-launches-and-market-share-gains-are-likely-to-override-pricing-erosion-6438411.html?utm_source=telegram&utm_medium=social
https://www.moneycontrol.com/news/business/moneycontrol-research/lupin-new-launches-and-market-share-gains-are-likely-to-override-pricing-erosion-6438411.html?utm_source=telegram&utm_medium=social
Moneycontrol
Lupin: New Launches And Market Share Gains Are Likely To Override Pricing Erosion
New launches in the US, particularly in the inhalation category, and an improving market share are expected to help ride over structural pricing erosion in the near term for Lupin
#MarketsWithMC: The share price of #Lupin fell more than 6% in the intraday trade today on #BSE. Brokerages express mixed views on the stock after the June quarter #earnings.
Read: https://www.moneycontrol.com/news/business/markets/lupin-shares-crack-6-amid-high-selling-pressure-post-q1-numbers-brokerages-remain-mixed-7323401.html?utm_source=telegram&utm_medium=social
Read: https://www.moneycontrol.com/news/business/markets/lupin-shares-crack-6-amid-high-selling-pressure-post-q1-numbers-brokerages-remain-mixed-7323401.html?utm_source=telegram&utm_medium=social
Moneycontrol
Lupin Shares Crack 6% Amid High Selling Pressure Post Q1 Numbers, Brokerages Remain Mixed
In 2021, the stock has gained 7 percent against a 14 percent rise in the benchmark Sensex
#Pharma: #Lupin has entered into a $248-million settlement agreement with the plaintiffs in an antitrust class-action #lawsuit against the company for the delayed launch of the anti-diabetic drug Glumetza generic in the US. Read ⏬
https://www.moneycontrol.com/news/business/companies/delayed-launch-of-glumetza-lupin-settles-case-for-248-million-7472811.html?utm_source=telegram&utm_medium=social
by Viswanath Pilla
https://www.moneycontrol.com/news/business/companies/delayed-launch-of-glumetza-lupin-settles-case-for-248-million-7472811.html?utm_source=telegram&utm_medium=social
by Viswanath Pilla
Moneycontrol
Delayed launch of Glumetza: Lupin settles case for $248 million
The law suits in US courts alleged that the 2012 settlement of patent litigation regarding Glumetza delayed the availability of generic alternatives, causing consumers to pay higher prices for the drug.
#Lupin's Goa oral solid formulation facility has received 7 observations from USFDA, which is mostly related to the investigation of out-of-specification (OOS) drug productions and material testing deficiencies.
https://www.moneycontrol.com/news/business/companies/lupins-goa-plant-usfda-finds-certain-investigation-material-testing-deficiencies-7498111.html?utm_source=telegram&utm_medium=social
https://www.moneycontrol.com/news/business/companies/lupins-goa-plant-usfda-finds-certain-investigation-material-testing-deficiencies-7498111.html?utm_source=telegram&utm_medium=social
Moneycontrol
Lupin's Goa Plant: USFDA Finds Certain Investigation, Material Testing Deficiencies
Lupin said the company is confident of addressing the observations satisfactorily
#StocksInNews | Trendlyne is showing Rakesh Jhunjhunwala’s holding in Lupin Pharma as ‘below 1%’ as of September 30, 2021.
by Gaurav Sharma: https://www.moneycontrol.com/news/business/stocks/rakesh-jhunjhunwala-reduces-stake-in-pharma-major-lupin-7579151.html?utm_source=telegram&utm_medium=social
#Stocks #Lupin #StockMarketIndia
by Gaurav Sharma: https://www.moneycontrol.com/news/business/stocks/rakesh-jhunjhunwala-reduces-stake-in-pharma-major-lupin-7579151.html?utm_source=telegram&utm_medium=social
#Stocks #Lupin #StockMarketIndia
Moneycontrol
Rakesh Jhunjhunwala Reduces Stake In Pharma Major Lupin
Trendlyne is showing Jhunjhunwala’s holding in the company as ‘below 1%’ as of September 30, 2021.
#ICYMI | Rakesh Juhunjhunwala needs no introduction and is well known for his uncanny ability to spot the opportunity well before the others. His investments where he made a killing are well documented.
Titan is one of his investments that was in the news very recently for the sharp rally it witnessed and made fortunes for its investors like Jhunjhunwala.
https://www.moneycontrol.com/news/business/stocks/rakesh-jhunjhunwala-reduces-stake-in-pharma-major-lupin-7579151.html
#shareholding #rakeshjhunjhunwala #Pharma #Lupin #Stocks
Titan is one of his investments that was in the news very recently for the sharp rally it witnessed and made fortunes for its investors like Jhunjhunwala.
https://www.moneycontrol.com/news/business/stocks/rakesh-jhunjhunwala-reduces-stake-in-pharma-major-lupin-7579151.html
#shareholding #rakeshjhunjhunwala #Pharma #Lupin #Stocks
Moneycontrol
Rakesh Jhunjhunwala Reduces Stake In Pharma Major Lupin
Trendlyne is showing Jhunjhunwala’s holding in the company as ‘below 1%’ as of September 30, 2021.
#MarketsWithMC | Shares of Lupin rose 2% intraday today to Rs 914.20 after the company received USFDA approval for sevelamer carbonate for oral suspension.
The stock touched a 52-week high of Rs 1,267.50 and a 52-week low.
Know at
https://www.moneycontrol.com/news/business/stocks/lupin-rises-2-on-usfda-nod-for-sevelamer-carbonate-used-in-treatment-of-chronic-kidney-disease-7869201.html
#BuzzingStocks #Lupin
The stock touched a 52-week high of Rs 1,267.50 and a 52-week low.
Know at
https://www.moneycontrol.com/news/business/stocks/lupin-rises-2-on-usfda-nod-for-sevelamer-carbonate-used-in-treatment-of-chronic-kidney-disease-7869201.html
#BuzzingStocks #Lupin
Moneycontrol
Lupin rises 2% on USFDA nod for sevelamer carbonate used in treatment of chronic kidney disease
The stock touched a 52-week high of Rs 1,267.50 and a 52-week low of Rs 854 on June 2, 2021 and December 20, 2021, respectively.
#TradeSetup for August 3rd ⚡️#Lupin, #Voltas, #AurobindoPharma And More!
These are the #stocks that will possibly be in the spotlight during #trading hours tomorrow.
Watch the video to know why these #stocks are buzzing before the #OpeningBell! 🎥 https://www.youtube.com/watch?v=p2yVd5ACfkIhttps://bit.ly/3OMZXEc
These are the #stocks that will possibly be in the spotlight during #trading hours tomorrow.
Watch the video to know why these #stocks are buzzing before the #OpeningBell! 🎥 https://www.youtube.com/watch?v=p2yVd5ACfkIhttps://bit.ly/3OMZXEc
#TradeSetup for September 30th ⚡️ #Lupin, Arvind SmartSpaces, #SRF and #TataCommunications
Check out this curated list of buzzing #stocks and why they are in the news 📹👇
https://youtube.com/watch?v=pkq9Rnl2pK0
Check out this curated list of buzzing #stocks and why they are in the news 📹👇
https://youtube.com/watch?v=pkq9Rnl2pK0
#TradeSetup for November 22nd ⚡️ FSN E-Commerce Ventures, #BlueStar, #Lupin & #JKPaper: Top Stocks To Watch On Tuesday
Check out this curated list of buzzing #stocks and why they are in the news 📹👇
https://www.youtube.com/watch?v=_Ttj_MChDVA
Check out this curated list of buzzing #stocks and why they are in the news 📹👇
https://www.youtube.com/watch?v=_Ttj_MChDVA
#TradeSetup for November 25th ⚡️ #Lupin, #PBFintech, #PNB & #LaurusLabs: Top Stocks To Watch On Friday
These are the stocks that will possibly be in the spotlight during trading hours on November 25th, Thursday. We explain the reasons why these stocks are buzzing before the Opening Bell and the factors that could come into play in trade.
Check out this curated list of buzzing #stocks and why they are in the news 📹👇
https://bit.ly/3gsV5cl
These are the stocks that will possibly be in the spotlight during trading hours on November 25th, Thursday. We explain the reasons why these stocks are buzzing before the Opening Bell and the factors that could come into play in trade.
Check out this curated list of buzzing #stocks and why they are in the news 📹👇
https://bit.ly/3gsV5cl
#TradeSetup for November 29th ⚡️ #NBCC, #Lupin , #CanfinHomes & #ArvindSmartSpaces: Top Stocks To Watch On Tuesday
Check out this curated list of buzzing #stocks and why they are in the news 📹👇
https://www.youtube.com/watch?v=8msHsgnigBw&feature=youtu.be
Check out this curated list of buzzing #stocks and why they are in the news 📹👇
https://www.youtube.com/watch?v=8msHsgnigBw&feature=youtu.be
On #MorningTrade 🔥
▶️ Railway-related shares in fast-track mode; Should you still buy after the recent rally?
▶️ We also analyse the stock chart of #Paytm, #Lupin & more
Tune in at 8.30am!
https://youtube.com/@moneycontrol
▶️ Railway-related shares in fast-track mode; Should you still buy after the recent rally?
▶️ We also analyse the stock chart of #Paytm, #Lupin & more
Tune in at 8.30am!
https://youtube.com/@moneycontrol
On #OpeningBell 🔔
▶️ Diagnostics stocks saw a smart surge amid renewed fears of #Covid outbreaks globally.
▶️ Catch Santosh Nair's thoughts on whether this rally will sustain and also catch his views on #SulaVineyards which makes its debut on the stock exchanges today and #Lupin.
LIVE @ 9AM!
🔗 https://www.youtube.com/watch?v=Qj6XsbLZTpo
▶️ Diagnostics stocks saw a smart surge amid renewed fears of #Covid outbreaks globally.
▶️ Catch Santosh Nair's thoughts on whether this rally will sustain and also catch his views on #SulaVineyards which makes its debut on the stock exchanges today and #Lupin.
LIVE @ 9AM!
🔗 https://www.youtube.com/watch?v=Qj6XsbLZTpo
YouTube
Stock Market Live: Diagnostics Stocks Back In Limelight Amid Covid Fears Can The Momentum Sustain?
Diagnostics stocks saw a smart surge amid renewed fears of Covid outbreaks globally. Shares of Dr Lal PathLabs, Metropolis Healthcare, Vijaya Diagnostic Centre and Thyrocare rallied up to 6% in yesterday as investors see brighter prospects for diagnostics…
Coming up on #MorningTrade 🔥
👉 TCS to kick-off Q3 earnings season; How will IT stocks react in results week❓
👉 Emirates NBD & Fairfax Group likely to have submitted EoI for IDBI Bank stake: Moneycontrol Exclusive
👉 Other stocks in focus: Titan, Tata Steel & Lupin
Live @ 8.30 AM
https://www.youtube.com/watch?v=Barc45jqtCk
👉 TCS to kick-off Q3 earnings season; How will IT stocks react in results week❓
👉 Emirates NBD & Fairfax Group likely to have submitted EoI for IDBI Bank stake: Moneycontrol Exclusive
👉 Other stocks in focus: Titan, Tata Steel & Lupin
Live @ 8.30 AM
https://www.youtube.com/watch?v=Barc45jqtCk
YouTube
Stock Market Live: Buy Or Sell Tech Shares Ahead of TCS Result? IDBI Bk, Titan, Tata Steel in Focus
TCS to kick-off Q3 earnings season; How will IT stocks react in results week? Emirates NBD & Fairfax Group likely to have submitted EoI for IDBI Bank stake: Moneycontrol Exclusive.
Other stocks in focus: Titan, Tata Steel & Lupin.
#live #nifty #stockmarket…
Other stocks in focus: Titan, Tata Steel & Lupin.
#live #nifty #stockmarket…
#TradeSetup for January 10th ⚡️#TCS, #Lupin, #SuvenPharma & #TataMotors: Top Stocks To Watch On Tuesday
Check out this curated list of buzzing #stocks and why they are in the news 📹👇
https://www.youtube.com/watch?v=O0iCLWSPA6Y
Check out this curated list of buzzing #stocks and why they are in the news 📹👇
https://www.youtube.com/watch?v=O0iCLWSPA6Y